Biotechnology and pharmaceutical ETFs powered ahead in the past month, handing profits-on-steroids to investors. A wave of mergers, robust pipelines and busier-than-ever hospitals continue to drive these industries forward. The iShares Nasdaq Biotechnology (IBB) -- a best-performing ETF in the past four weeks and year to date -- has big stakes in IBD Leaderboard stock Illumina (ILMN), a leader in the field of genetic testing kits. ETF investors
Tuesday 14 July 2015
As Biotech Beats, 6 Top ETF Picks For Rest Of 2015
Otmane El Rhazi from Investor's Business Daily - ETFs RSS.
Biotechnology and pharmaceutical ETFs powered ahead in the past month, handing profits-on-steroids to investors. A wave of mergers, robust pipelines and busier-than-ever hospitals continue to drive these industries forward. The iShares Nasdaq Biotechnology (IBB) -- a best-performing ETF in the past four weeks and year to date -- has big stakes in IBD Leaderboard stock Illumina (ILMN), a leader in the field of genetic testing kits. ETF investors
Biotechnology and pharmaceutical ETFs powered ahead in the past month, handing profits-on-steroids to investors. A wave of mergers, robust pipelines and busier-than-ever hospitals continue to drive these industries forward. The iShares Nasdaq Biotechnology (IBB) -- a best-performing ETF in the past four weeks and year to date -- has big stakes in IBD Leaderboard stock Illumina (ILMN), a leader in the field of genetic testing kits. ETF investors
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment